| Names | |
|---|---|
| Preferred IUPAC name | 4-(2-methylpropoxy)benzoic acid |
| Other names | Isobutyl p-hydroxybenzoate 2-Methylpropyl 4-hydroxybenzoate |
| Pronunciation | /ˌaɪ.soʊˈbjuː.tɪlˌpær.ə.bɛn/ |
| Identifiers | |
| CAS Number | 4247-02-3 |
| Beilstein Reference | 1360062 |
| ChEBI | CHEBI:85272 |
| ChEMBL | CHEMBL2105972 |
| ChemSpider | 5326 |
| DrugBank | DB14042 |
| ECHA InfoCard | 03b2b279-753c-40c2-8c36-5fab0d3d9de1 |
| EC Number | 202-253-6 |
| Gmelin Reference | 8146 |
| KEGG | C10781 |
| MeSH | D017370 |
| PubChem CID | 7121 |
| RTECS number | NT8050000 |
| UNII | TOV31213GD |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C11H14O3 |
| Molar mass | 194.23 g/mol |
| Appearance | White crystalline powder |
| Odor | Faint characteristic odor |
| Density | 1.06 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 2.4 |
| Vapor pressure | 0.000183 hPa (25 °C) |
| Acidity (pKa) | 8.43 |
| Basicity (pKb) | 8.42 |
| Magnetic susceptibility (χ) | -63.0e-6 cm³/mol |
| Refractive index (nD) | 1.509 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.97 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 362.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –663.9 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | –7100.0 kJ/mol |
| Pharmacology | |
| ATC code | D08AE08 |
| Hazards | |
| Main hazards | May cause skin and eye irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0-~ |
| Flash point | > 109°C |
| Autoignition temperature | 530°C |
| Lethal dose or concentration | LD50 (Rat, oral): 13,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, Rat: 16,000 mg/kg |
| NIOSH | NT0800000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.01% |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Methylparaben Ethylparaben Propylparaben Butylparaben Isopropylparaben Benzylparaben |
| Property | Detail | Technical Commentary |
|---|---|---|
| Product Name & IUPAC Name | Isobutylparaben IUPAC: 4-Hydroxybenzoic acid, isobutyl ester |
In the plant, the naming accuracy supports regulatory submissions and quality assurance traceability. The IUPAC structure is referenced at every QC checkpoint to avoid isomeric or structural misidentification in analytical testing, particularly important for regulatory documentation and export compliance. |
| Chemical Formula | C11H14O3 | The molecular formula is integral for selecting analytical standards and calibrating quantification methods in synthesis and release testing. Material mass balancing in production and impurity mapping during QA review both rely on the confirmed stoichiometry of this ester. |
| Synonyms & Trade Names | Isobutyl p-hydroxybenzoate, Isobutyl 4-hydroxybenzoate, E216 | Shipment documents and customs paperwork use synonyms to match international regulatory lists. Naming consistency also becomes important while interacting with customers who may reference trade names or E codes, especially in regions with differing nomenclature standards. Synonym use in the lab aids cross-referencing older analytical literature as the compound finds varied use in personal care, preservative applications, and industrial blends, often under diverse trade terminology. |
| HS Code & Customs Classification | Commonly reported under HS Code 2918.23 | HS Codes reflect the global movement of isobutylparaben. Customs declarations must align with national chemical control lists and tariff categorization; regular classification audits ensure accuracy in customs filings. In practice, manufacturers monitor periodic updates to tariff codes as chemical control regulations evolve due to shifting concerns about preservative usage, especially in high-volume export markets. The classification choice impacts import procedures, documentation bundles, and the need for local regulatory dossiers. Manufacturers typically coordinate with logistics compliance teams to ensure code alignment across multiple jurisdictions where formula, form, and declared use may shift the code slightly. |
In industrial production, isobutylparaben is commonly isolated as a white to off-white crystalline powder. The presence of any discoloration or unexpected odor in a manufactured lot often signals either incomplete purification or secondary reactions during drying. Melting point and other thermal properties run dependent on both the grade produced and application requirements. Trace impurities from synthesis often influence powder appearance, and strict control reduces off-color material or off-odor indicative of hydrolytic degradation.
Broad production batches typically observe melting points within a range indicative of product purity. Low-melting fractions, or material softening below expected range, reflect residual solvents or incomplete crystallization. Flash point assessment gets performed in compliance with regulatory method requirements. Consistency in thermal transitions affects shelf stability and risk classification under transport regulations.
Apparent bulk density is batch and grade dependent, influenced by crystallization solvent, drying technique, and particle size adjustment during final production steps. For direct blending, compounding, or tableting, density may require close adjustment via post-processing, especially in pharma and personal care applications.
Esters like isobutylparaben display susceptibility to hydrolysis in atmospheres with elevated moisture or alkaline pH. Production experience demonstrates greatest stability in anhydrous, inert-packaged form, especially for material destined for high-stability formulations. Exposure to light and air, particularly at elevated temperature, can initiate slow decomposition; thus, atmospheric controls in packaging lines factor into final product stability. Batch records address reactivity incidents, especially if stored or processed outside recommended conditions.
Solubility profiles are grade-dependent. Cosmetic and pharma customers may specify solubility limits in water, alcohols, and glycols, which shift with particle size and surface treatment from manufacturing. For consistent formulation performance, controlled dissolution trials are routinely performed post-lot production, and process settings adjusted for end-user processability requirements.
Detailed specification limits, such as assay, melting range, color, and moisture, depend on the chosen product grade and application, e.g., pharmaceutical versus industrial preservative. Parameters may be tightened or expanded according to individual customer contract and target regulatory jurisdiction. Official specification tables are maintained by the quality control department and align with the release protocols for each lot.
Process-related impurities, such as unreacted starting material, by-product esters, or hydrolysis fragments, are minimized through stepwise purification. Actual impurity profile is determined according to both internal standards and end-user requirements. Final release limits and acceptable impurity levels are reviewed per application—stricter for injectable or high-purity cosmetic uses. Unexpected impurity spikes often direct a root-cause investigation in the production line.
Assay and purity are routinely measured by validated chromatographic techniques such as HPLC. Moisture levels are commonly verified through Karl Fischer titration. For color and clarity, visual and instrumental checks are calibrated as part of internal QA protocols. Test standards often reference international pharmacopeias or ASTM methods, but adaptation to specific customer requirements is performed on agreement.
Consistent product quality begins with high-purity paraben acid derivative and isobutanol. Raw material vendors undergo formal qualification, including impurity mapping and lot traceability assurance. Variability in feedstock quality triggers additional pre-batch purification or lot rejection before synthesis starts.
Esterification of p-hydroxybenzoic acid with isobutanol represents the standard route, catalyzed by acid or enzymatic system. The choice of catalyst and reaction conditions influences impurity formation, reaction time, and environmental emissions. Where possible, closed-system reactors with controlled atmospheres reduce byproduct and contamination risk, especially for pharma and food grades.
In-process control points monitor reaction conversion, residual starting material, and by-product formation. Final purification generally involves fractional crystallization and filtration, with solvent recovery and in-line monitoring supporting batch consistency. Deviations in process control readings trigger hold or reprocessing; production logs are maintained for regulatory review and customer audit.
Each lot undergoes retention sampling, full specification testing, and stability trials for select grades. Lot release requires conditional approval by QA/QC managers, with documentation supplied for each shipment outlining compliance with declared specifications and testing summary. Adjustments to release criteria are guided by audit feedback and post-market surveillance data.
Isobutylparaben retains an ester linkage, allowing hydrolysis under acidic or basic conditions to the parent acid and isobutanol. Further reaction yields derivatives suitable for tailored functional profiles in specialty applications, dependent on reaction partner and media choice.
Catalyst selection—acidic or enzymatic—aligns with downstream purity and application requirements. Temperature and solvent choice (e.g., toluene, xylene, or alternative eco-solvents) influence both yield and safety profile in plant operation. Regular review of operating limits ensures safe containment and energy management for each scale-up campaign.
Paraben derivatives serve as intermediates for a range of cosmetics, personal care products, and specialty polymers. Customer-driven modification work often involves fine-tuning alkyl chain length, conjugation with solubilizers, or derivatization for antimicrobial optimization. Each step demands new impurity mapping and validation before market release.
Optimal retention occurs in cool, dry, and shaded environments. Light exposure and high humidity accelerate degradation, especially in open-top bins or poor-sealing bags. Some users specify nitrogen blanketing for long-term storage or high-purity reserve inventory. Plant-wide storage SOPs define handling restrictions based on risk and expected turnover interval.
HDPE drums and lined fiber drums are favored for bulk shipments. Contact with metals or permeable packaging risks contamination and off-flavor or odor development, particularly in food or pharma grades. Container selection takes into account compatibility tests and end-use-specific requirements.
Shelf life varies by grade, package, and lot turnover. Quality retention is usually confirmed by periodic retesting for key parameters, with degradation often apparent in color yellowing, surface clumping, or odor note development. Out-of-spec lots are flagged for secondary use, rework, or safe disposal.
GHS classification assigns risk based on acute toxicity and irritancy data for isobutylparaben. Internal safety data sheets carry latest harmonized statements for handling and transport. Updates are managed according to changes in international regulatory frameworks and incident reporting.
Safety labeling reflects known routes of potential exposure—primarily dermal and respiratory. Control measures across process plants include forced-air ventilation, personal protective equipment, and controlled-access bulk handling. Emergency procedures and spill management protocols align with site-level process safety review results.
Acute toxicity assessments derive from published toxicological studies. Manufacturing operators adhere to company-internal exposure control measures, with ongoing surveillance for new regulatory or customer-driven threshold changes. Chronic exposure evaluations—particularly for workers in large-scale or continuous processing—trigger periodic review of air monitoring and biological sampling data. PPE requirements and engineering controls remain under active assessment based on evolving technical literature and health authority advice.
Production lines for isobutylparaben typically integrate direct esterification procedures using high-purity p-hydroxybenzoic acid and isobutanol under sulfuric acid or alternative acid catalysis. Capacity depends heavily on upstream availability of high-grade raw materials and purification throughput. Annual output scaling is tied to the reliability of raw material contracts, reactor utilization, and demand-driven scheduling. Short-term disruptions often stem from logistic bottlenecks or fluctuations in upstream petrochemical feedstocks.
Lead times mainly reflect current reactor scheduling and purification load. Orders matching standard batch sizes can often be released within several business days when stock is available, but larger or custom grades with strict impurity cut-offs take additional time due to analytical release testing. Minimum order quantities are generally linked to the typical batch capacity for the selected grade—smaller runs significantly increase per-unit cost due to changeover and cleaning.
Available packaging depends on product grade and end-user regulatory requirements. Pharmaceutical and personal care grades are packaged in sterilized, certified containers with full material traceability; industrial or technical grades are filled in fiber drums, HDPE containers, or bulk bags based on client logistics. Sealing, moisture barrier, and labeling methods vary according to product sensitivity to light, humidity, and cross-contaminants.
Shipping methods are selected based on cargo classification per IMDG, IATA, and recipient region—sea, road, or air freight is offered with compliance to relevant environmental and safety stipulations. Payment term flexibility is determined by credit verification and ongoing business relationship duration. Letter of credit, TT payment, and select deferred settlement are considered for established partners with verified procurement processes.
Isobutylparaben pricing is built from the cost of p-hydroxybenzoic acid, isobutanol, catalyst, and energy input. p-Hydroxybenzoic acid, derived from petrochemical routes, drives the bulk of input costs. Crude oil and aromatic hydrocarbon index volatility impact this precursor’s market price. Isobutanol supply instability also moves the needle, particularly during refinery shutdowns or export curbs. The degree of raw material purification required dictates input premiums.
Feedstock prices track the global crude and specialty chemicals indices, affected by refinery maintenance, natural disaster disruptions, trade policy shifts, and environmental regulation changes. Regulatory crackdowns on intermediate emissions or import quotas can restrict feedstock flow, leading to upward price pressure for base chemicals. Distribution of raw material grade, especially for paraben precursors destined for pharmaceutical use, often narrows global spot availability and increases procurement cost.
End price depends on three variables: grade specification, targeted purity, and packaging/handling compliance. Pharmaceutical and personal care grades require batch-level analytical validation, sterilized packaging, and occasionally DMF or similar regulatory filings, which increase processing and certification costs. Technical grades, intended for industrial applications, follow less intensive quality gates, reducing overhead. Differences in packaging (unit size, material, inert gas blanketing, tamper evident sealing) further add direct cost to certified lots. Purity and impurity profiles, governed by downstream usage, remain the primary drivers of price stratification within the product line.
Global isobutylparaben supply reflects the structure of the personal care, cosmetic, and preservative markets in North America, Europe, East Asia, and South Asia. Regulatory scrutiny over paraben usage in developed economies has impacted demand growth, but technical substitution and expansion in non-cosmetic sectors have supported baseline volumes. Short-term tightness often arises from periodic shutdowns at upstream intermediate plants—rebalancing follows as producers in China and India reallocate exports.
United States demand reflects the evolution of FDA and consumer perception about paraben safety in cosmetics; downstream processors favor grades with comprehensive toxicological portfolios. European Union requirements drive demand for tested product with trace impurity controls, aligning with stringent REACH mandates. Japanese buyers source high-purity, batch-certified materials due to local pharmacopoeia and quasi-drug requirements. India and China anchor the majority of global capacity and frequently export technical and pharma-intermediate grades, with India increasingly adopting higher quality standards due to expanding local regulated-market production.
Market consensus expects a moderate strengthening of isobutylparaben pricing toward 2026, with the transition anchored in raw material input costs and evolving regulatory scrutiny around preservatives. Feedstock price increases, especially in an elevated crude oil market, will flow through to final product prices. Continued compliance demands from Western and East Asian markets prompt higher-grade segment growth, with a widening price gap between certified and generic grades. Should restrictions on paraben use tighten in personal care, substitution trends could modulate demand, but technical application expansion moderates strong downside risk.
Internal pricing models use a blend of procurement cost tracking, global feedstock index movements, contract settlement data, and periodic client-side feedback. Market forecasts leverage third-party chemical analytics, disclosed regulatory bulletins, and downstream application forecasts in regulated and unregulated sectors. Data triangulation includes primary plant operational reporting and import/export analysis from customs releases.
Recent adjustments in supply contracts for p-hydroxybenzoic acid and isobutanol have reshaped procurement risks, particularly with new export control measures in East Asia. Downstream personal care launches featuring alternative preservative systems have not significantly reduced core demand, though product portfolios expand toward multi-preservative blends.
Ongoing changes to regional preservative regulations, specifically the EU SCCS guidelines on allowable concentration, have prompted batch release specification reviews. Compliance documentation for high-purity and batch-certified grades reflects the most recent pharmacopoeial and ingredient registration changes globally.
Supply chain risk mitigation centers on diversifying upstream sourcing and upgrading traceability throughout the production workflow. New investments in in-process control and final batch analytics aim to proactively demonstrate regulatory and toxicological compliance, supported by transparent auditing of purification, packaging, and shipping practices. Collaboration with major downstream users ensures alignment of test parameters and documentation with final-use regulatory needs, anchoring product reliability within increasingly dynamic market and compliance frameworks.
Isobutylparaben finds use primarily in personal care, cosmetic, and pharmaceutical formulations as a preservative. Demand comes from manufacturers requiring microbial control in creams, lotions, shampoos, and topical medicines. Occasionally, requirements arise from specialty industrial and food contact segments, but such use typically follows more restrictive regulations and specialized grade demarcations.
| Application Segment | Typical Isobutylparaben Grade | Critical Grade-Specific Considerations |
|---|---|---|
| Cosmetics/Toiletries | Cosmetic/Personal Care Grade | Regular focus on purity and sensory profile, usually relies on grades with controlled organoleptic properties (odor, color). Trace solvent residues and related substance profiles require careful monitoring per global or regional cosmetic regulations. The main inspection parameter is purity; color and odor serve as batch-to-batch check points. |
| Pharmaceuticals (Topical) | Pharma (USP/Ph. Eur.) Grade | Requires documentation aligning with pharmacopeial monographs; stricter upper limits for individual and total impurities. Residual solvent control reflects ICH guidelines, so production routes must support low-level detection of process-related impurities. Routine release batches must pass stringent documentation, chain-of-identity, and retention sample protocols. |
| Industrial/Technical | Industrial/Technical Grade | Target application dictates allowable impurity levels; downstream impact of color, odor, trace organic content is often less critical. Purity levels and contaminant control match customer-specific or internal specifications—often with custom parameters based on downstream compatibility. |
Cosmetic and pharma applications most commonly scrutinize assays, color (APHA/Hazen), odor, moisture (by KF), and residual solvent profile. Impurity evaluation includes identification and quantification of O-methylparaben, related esters, and process-related organics. For pharma, a focus extends to endotoxins (for some select markets), and documentation must include comprehensive traceability and retention record.
Industrial grades prioritize process compatibility and price-performance, sometimes adjusting limits on color, odor, or non-critical impurities in tandem with customer processing tolerance.
Identify the end-use as specifically as possible: cosmetic, topical pharmaceutical, or technical process auxiliary. For each, intended product exposure must drive the grade selection and quality documentation needed.
Investigate the product compliance requirements for all markets where the final formulation will distribute. Cosmetics often reference EU or FDA lists, and pharma must meet region-specific pharmacopeial standards. Industrial buyers may define particular in-house contaminant thresholds that reflect their own product standards.
Select from available grades by comparing the required assay minimum, organoleptic property limits (odor, color), and impurity profile controls. Cosmetic and pharma sectors typically select the highest-purity grades with the tightest specification for trace solvents and related esters. Technical grades focus on major contaminants only as dictated by downstream sensitivity.
Projected consumption volume interacts directly with available package sizes and supply arrangements. For large contract orders or multi-ton requirements, batch consistency and logistical assurance take precedence. Budget constraints sometimes call for negotiation on critical versus non-critical impurity tolerances or alternative packaging, especially in non-pharma applications.
Before full adoption, request a batch sample and apply it in actual product formulations or simulated process conditions. Review certificate of analysis and quality documentation alongside physical/chemical testing, considering assay, organoleptic, and process-behavior criteria.
Final qualification relies on side-by-side comparison with existing material or a specific customer-developed protocol to ensure compatibility, stability, and performance meet all technical and regulatory benchmarks.
Production of isobutylparaben aligns with established quality management frameworks such as ISO 9001, maintained through ongoing third-party audits and continuous improvement initiatives. Documentation from these audits remains available for technical and regulatory review. Batch records, change control protocols, and deviation investigations are part of our traceable manufacturing system, ensuring materials, processes, and operations receive review at each stage of manufacture.
Certification schemes relevant to isobutylparaben depend on targeted applications—cosmetic, pharmaceutical, or industrial. For cosmetic or personal care applications, compliance with local and regional regulations such as EU REACH, U.S. FDA 21 CFR, or other specific chemical inventories is maintained per market requirements. Declarations of purity, allergen status, and residual solvent assessments are included with each lot, recognizing that final benchmarks reflect both internal release specifications and end-use customer or regulatory requirements. Certification type depends on the designated use and grade; contact is necessary to match product documentation with actual demand.
A full dossier accompanies each batch, including certificate of analysis (COA), tracking analytical data against specification tables defined for each product grade. Test methods typically follow industry-standard or customer-specified protocols. Shelf life and storage recommendations result from real-time and accelerated stability studies. Safety Data Sheets (SDS) meet current GHS requirements for principal target markets and reflect upstream impurity studies from raw material risk assessments. Non-confidential validation reports and recent regulatory updates are provided upon request, case-by-case, respecting grade and jurisdictional variation.
Manufacturing infrastructure for isobutylparaben is configured for multi-ton scale throughput, with production schedules optimized for demand profiles received from contract partners. Raw material sourcing relies on contract-verified suppliers with traceable incoming QC, allowing for rapid adaptation to swings in customer forecasts or changes in regulatory specifications. Flexible cooperation models support both spot purchases for pilot validation and ongoing contract supply, ensuring stable access regardless of order cadence.
Multiple production lines and robust process redundancy guard supply stability, even when upstream logistics fluctuate. Preventative maintenance and scheduled shutdowns follow industry-standard planning cycles to minimize interruptions. Capacity allocation across customer tiers is reviewed periodically using real usage data, not speculative forecasting, to ensure consistent delivery for recurring OEM or formulation manufacturing demand. Adaptations for periodic surges can be negotiated at the contract stage, subject to raw material availability and confirmed technical feasibility.
Sample requests for isobutylparaben proceed through technical evaluation to match the most appropriate grade to the intended application. Samples undergo the same QC release as production batches, including COA and SDS, unless a special protocol is pre-negotiated. Requests typically require disclosure of intended use, minimum required quantity, and deadline constraints, alongside a brief description of application environment if analytical customization is necessary.
Business cooperation options include fixed-period supply agreements, minimum call-off quantities, or project-based delivery for short-cycle development work. Terms may allow for adjustable call-offs, safety stock arrangements, consignment inventory, or joint forecasting, depending on customer production volatility. Modifications to standard operating procedures, packaging requirements, or special certification bundles can be integrated into supply contracts once feasibility is cleared by all relevant internal departments. Feedback channels remain active throughout cooperation, supporting mid-stream specification revision if mandated by downstream discovery, regulatory change, or process optimization.
Technical teams in chemical manufacturing focus on optimizing para-hydroxybenzoic acid esterification as the primary route for isobutylparaben. Attention centers on intermediary purity control, catalyst selection, and energy optimization. R&D interest also builds around reducing by-product formation from side-chain cleavage and controlling residual solvents to trace levels, as required for high purity or pharmaceutical grades.
Grades intended for personal care and cosmetics drive substantial investment in contaminant profiling, especially with regional differences in regulatory scrutiny. Researchers continue to investigate alternative solvent-free and solid-acid catalyzed routes, particularly for regions with stringent waste minimization laws.
Market growth appears in sectors targeting paraben alternatives with low toxicity profiles and well-characterized impurity distributions. Technical requests emerge from formulators in preservation-sensitive products, such as certain cosmetics and specialty adhesives, seeking preservatives compatible across a broader range of matrices without phase separation. Some inquiries arrive from niche pharma intermediates sectors requiring customized isobutylparaben grades with tailored impurity fingerprints.
Solid impurity carryover, trace color impurities, and odor development under high storage temperature conditions remain active technical hurdles. Successful batch-to-batch odor reduction through secondary purification steps—such as vacuum distillation refinement or chromatographically guided impurity tailing—has gained ground in recent years. Technical teams report breakthroughs in maintaining low residual solvent values by integrating real-time vapor-phase monitoring with process endpoint automation.
Demand forecasts anticipate moderate volume growth in personal care and formulated product sectors where consumer preference moves toward documented preservative science and traceability. Areas observing expanding use include preservation systems in water-sensitive and high-pH products. Buyers and regulators both want increased transparency regarding raw material provenance and residual impurity tracking. Demand remains grade-specific and sensitive to local regulatory changes; technical dialogue with customers over impurity limits and analytical traceability influences expanded adoption.
Technical advances point toward modular reactors and closed-loop purification, reducing environmental footprint and batch variability. Isolated process steps, such as integrated quench filtration and solvent recovery, reflect an industry trend toward minimizing cross-contamination risks and facilitating faster grade-switching capability. Analytical support for rapid identification of trace-level contaminants increasingly requires advanced spectroscopy and chromatography, especially for export-regulated grades.
Process streamlining has already reduced non-target effluent generation. Technical development teams evaluate biomass-derived raw material for feedstock sustainability, although conversion yield and impurity drift remain under study. Solvent-free or recyclable catalyst systems receive continuous assessment, with pilot line trials demonstrating reduced total process solvent load for some specialty grades. Further integration of green chemistry principles depends on compatibility with current high-volume production infrastructure and the capability to maintain release specification integrity.
Technical service teams field detailed queries from compounders and formulators regarding impurity identification, minimum detectable color, and reactivity with formulation excipients. Support often involves providing historical process route information, downstream compatibility data, and grade-specific impurity analysis to address validation and regulatory questions.
Application engineering focuses on optimizing blend homogeneity and solubilization rates specific to customer matrices. Support includes practical guidance on managing precipitation, microcrystal formation, and maintaining desired preservative properties under various formulation pH and temperature profiles. Customers with complex process integration requirements receive stability testing protocols and migration predictive modeling, tailored per application.
After-sales response includes technical troubleshooting for lot-to-lot performance variations and rapid root-cause analysis in case of rare out-of-spec performance. For customers requiring continuous process validation or recurring impurity trend reports, the quality control group supplies statistical batch history and traceable release documentation. Supply consistency, technical traceability, and timely analytics constitute the backbone of after-sales relationships, ensuring ongoing alignment with evolving formulation and regulatory standards.
Our facility produces Isobutylparaben at scale using proven, robust chemical synthesis. Each batch starts with carefully selected raw materials, processed in reaction vessels under controlled temperature and pH conditions. By maintaining full control over the production process, we deliver consistent material quality that meets industrial-grade specifications, lot after lot. Years of process refinement have stabilized yield and purity, keeping off-spec results out of the supply chain.
Isobutylparaben sees the bulk of its use in cosmetics, personal care, and pharmaceutical preservation systems. Formulators in these sectors count on reliable antimicrobial performance, stable shelf life, and tight impurity profiles. Our manufacturing setup supports these requirements with monitored content of active substance and restricted byproducts. Consistency in microbial barrier properties allows our direct industrial customers to manage compliance and reformulation with confidence.
Quality assurance stands as a company-wide priority. Every order ships with batch-specific analysis certificates backed by a traceable production record. In-process testing confirms both chemical identity and assay strength before release. We conduct regular equipment qualification, staff training, and environmental monitoring to deter deviation, both for regulated and technical grades. Buyers expect predictability, and we commit our production resources to deliver exactly that.
Our lines support diverse packaging—fiber drums, steel containers, and specialty intermediate bulk containers for large-scale operations. Package sealing and labeling take place under cGMP conditions. Bulk orders fill through automated lines for high throughput, while custom packing options serve smaller runs or specialized storage requirements. As a direct producer, we forecast and reserve raw materials to support repeat industrial demand, reducing the risk of allocation squeezes.
Technical queries reach our chemical engineers—those who oversee both development and daily production. These experts assist with application specifics, stability data, and regulatory documentation requirements. Buyers draw on this knowledge to resolve scale-up, blending, and compliance queries at any production phase. On-site expertise allows us to troubleshoot formula compatibility and respond with practical, plant-backed solutions for industrial customers.
Direct manufacturing control cuts uncertainty out of supply arrangements. Industrial procurement teams benefit from planned availability, batch traceability, and integrated technical service. Distributors gain persistent access to high-quality stock, reducing inventory risks. End manufacturers avoid production delays or reformulation costs linked to inconsistent ingredient quality. By integrating production, QC, support, and logistics, we drive efficiency and reliability throughout the value chain.
Every lot of isobutylparaben we produce gets its start with a clear focus on purity and consistency. Process control in our plant remains tight from raw material intake through to finished material testing. We run continuous in-process checks that let us catch even minor variations before they get a chance to enter bulk production. This commitment shapes both the actual purity of our batches and the reliability repeat customers count on.
Isobutylparaben rolls out of our facility at a chemical purity of not less than 99.0%, assayed by high-performance liquid chromatography as per quality control protocols. This number isn’t just for paperwork—it reflects the upper threshold consistently achievable using established manufacturing chemistry without introducing avoidable risk or instability. Keeping residual impurities below 1% isn’t something we manage by wishful thinking. It comes from ongoing work in refining filtration and purification techniques, as well as real-time batch tracking.
Customers in pharmaceuticals and cosmetics often ask about the reasons behind a 99.0% threshold. Rigorous purification increases cost and energy demand exponentially beyond this point. We build our process to minimize residual organic solvents, unreacted starting material, and byproducts, which remain tightly monitored by our technical staff. Each finished lot is validated in-house with full traceability back to source ingredients, which eliminates cross-contamination concerns. Results put through our QA laboratory reflect actual sampled product, not hypothetical documentation.
We use liquid chromatography methods calibrated with authenticated reference standards, following audit-ready practices. Typical COA reports for our isobutylparaben show a purity readout, moisture content, and melting point, with identification curves included for qualified buyers who require batch traceability. Many customers focus on “minimum 99.0%” as the practical mark of performance, but we provide full datasets—assay, appearance, color metrics, and specific impurity profiles—where industry requirements demand closer scrutiny.
Raw data points serve a real purpose: major cosmetic and pharmaceutical firms need confidence in both batch stability and regulatory compliance. Unless a customer requests higher purity for niche application, we supply to the recommended monograph specs for mainstream use. This means nobody has to wonder what they are really getting or if the batch varies from drum to drum.
Our technical support team includes analytical chemists who oversee the validation of every batch prior to release. By maintaining all quality steps in-house—sourcing, synthesis, crystallization, QC assay—every shipment reflects the controls applied in our own facilities. Rejected lots do not reach customers. We believe this hands-on approach provides more meaningful reliability than simply citing generic standards or offloading quality issues downstream.
Years of making isobutylparaben have taught us that transparency with quality data is indispensable. We always make assay records, manufacturing protocols, and supporting test results available upon request. This direct-from-plant approach protects our business partners from both technical risk and regulatory challenge. End-users never have to speculate on batch-to-batch variability, because the documentation comes straight from our production line to their purchasing desk.
If there are ever questions about specification details, our technical staff engage directly, not via layers of intermediaries. That close connection is how production standards move forward, not just for meeting current expectations but for setting the benchmark for the next generation of isobutylparaben.
Out on the production floor, we see firsthand why minimum order quantity (MOQ) and lead times matter so much for Isobutylparaben. Real manufacturing means working to scale—batch sizes, equipment calibrations, and safety stock strategies all drive what’s practical. Isobutylparaben isn’t a niche, low-volume run for us. Our lines are engineered to deliver industrial quantities, so small batch requests simply don’t match up to the economics or scale of our operation.
Our MOQ reflects more than just material costs. Each campaign needs raw material procurement, labor, equipment scheduling, testing, and packaging. Running a few drums doesn’t justify the same setup and quality control costs as full pallet or tanker shipments. To keep quality consistent, we standardize production runs in the multi-hundred-kilogram range. This approach supports stable quality attributes from lot to lot and ensures each customer’s critical formulation parameters stay locked in.
From a cost and quality angle, larger batch sizes help us trace every lot directly to the date of production. If a customer ever needs to track back a shipment, transparent traceability gives confidence that each drum’s documentation matches exactly. That’s critical for audits, especially for customers working in personal care, pharmaceuticals, or sensitive food contact materials.
Real lead times don’t start when an order arrives and end when goods leave the gate. We forecast raw material requirements months ahead, balancing between core repeat orders and swing capacity for new contracts. Isobutylparaben needs precise synthesis, multi-stage purification, and strict quality testing. These steps take several working days, not hours. Even our most agile lines require dedicated setup and clean-down to eliminate cross-contamination with other parabens or specialty chemistries.
For our long-term partners, we maintain forecast-based inventory buffers, but spot orders or custom specifications go into our production queue as soon as we define requirements. Lead time has everything to do with material scheduling, workforce planning, and logistics alignment. If our production calendar is full, orders line up based on booking date. In cases where demand surges, there’s no instant reset; building additional capacity means hiring, equipment procurement, and validation.
Weather, transportation, regulatory approvals, and even global incidents (such as port disruptions or raw material market changes) can ripple through to delivery schedules. Because of this, we work closely with customer procurement teams to structure delivery windows that reflect both operational realities and downstream business goals. For larger volume contracts, staggered or scheduled deliveries can give flexibility to both sides of the partnership.
We believe planning and open communication remove many headaches. Customers who share forward forecasts get prioritized production slots and more predictable allocations. Our technical and commercial teams engage early in the buying cycle, mapping batch sizes to the most efficient campaign volumes possible. If a customer faces a raw material crunch, we're in a position to discuss short-term allocation, provided long-term collaboration is in place.
Strict MOQ policies and lead times reflect the realities of chemical manufacturing—not arbitrary policies. We encourage all partners to talk with our technical managers about integration with their own demand planning and logistics software. We see best results when both sides treat procurement of Isobutylparaben as a critical supply chain partnership, not just a transactional purchase.
Manufacturing isobutylparaben brings us questions about regulatory compliance more than any other preservative. The European Union’s REACH regulation and the US FDA’s expectations frame our entire operation for cosmetics and pharma ingredients. Isobutylparaben has faced increased scrutiny and regulatory changes over the last decade, mainly from concerns around endocrine activity and consumer safety. The EU’s Cosmetic Regulation (EC) No. 1223/2009 is especially strict on which parabens are allowed and at what concentrations. Isobutylparaben, along with isopropylparaben and phenylparaben, is currently banned for use in personal care and cosmetic products across the EU market. This restriction remains in place, regardless of whether the intended concentration falls below the prior permissible threshold.
As a direct manufacturer, we adopted these regulatory updates into our own production strategy. Over the past few years, our technical team restructured our product lineup and compliance documentation. For clients manufacturing goods aimed at the European market, we do not recommend using isobutylparaben at all. Even if a product is for export only, REACH obligations still apply to factories operating within the EU—meaning any handling of isobutylparaben involves additional oversight and justification, which most finished-product companies avoid altogether. This drives demand toward alternative approved preservatives. We work with R&D labs to find viable substitutes and share our experiences developing product prototypes without isobutylparaben in the blend.
Across the Atlantic, the US regulatory environment is more flexible, but not immune to scrutiny. The FDA maintains a list of ingredients it regards as safe for cosmetic use, provided manufacturers do not make medical claims or exceed concentrations that may pose a health risk. Isobutylparaben remains allowed in the United States for both cosmetic and certain pharmaceutical formulations, subject to Good Manufacturing Practice (GMP) rules. Our technical documentation covers historical safety assessments, as well as ongoing monitoring of any shifts in FDA policy or scientific review.
We maintain current Safety Data Sheets (SDS) and Certificates of Analysis (COA) for every production lot. Updated SDS documents detail hazard identification, recommended safe handling measures, disposal guidelines, and first aid advice. Our COA includes measured values for assay (purity), moisture content, melting point, residue on ignition, and identification through IR spectroscopy. Regulatory compliance data forms part of each COA, supporting customers with their own registration, ISO, or internal audit needs. Our technical support team can provide digital copies of SDS and COA, including batch-specific information, as soon as a new order is released or a sample is requested.
As a manufacturer, up-to-date compliance knowledge is more than an obligation—it’s integral to responsible practice. Our facility regularly undergoes regulatory training, and our R&D chemists follow global industry literature to ensure that our processes anticipate, not just react to, changes in policy. If new regulatory opinions or safety findings come to the forefront, our team makes adjustments to both our internal controls and customer-facing technical documents.
Tighter restrictions in specific regions drive innovation and transparency across the preservative segment. Our customers rely on our ability to not only provide compliant ingredients but also guide them toward safer, widely accepted alternatives when needed. Our technical department can discuss experiences developing formulations without isobutylparaben and help customers pivot to other parabens or entirely new preservative classes on short notice.
Direct engagement with evolving standards, detailed documentation for every order, and a collaborative approach with our partners keep us ready for the next regulatory chapter—no matter which region comes under the spotlight.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
